EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms

Gaurav Awasthi, Subham Banerjee

RSC Pharmaceutics · 2026 · 3 (3) · 768-777

DOI: 10.1039/d6pm00014b ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Gaurav Awasthi und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In silico studies were combined with in vitro validation to u nderstand the landscape of DEIs for further development of a stable solid oral dosage form.

Zitieren

APA

Awasthi, G., & Banerjee, S. (2026). Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms. RSC Pharmaceutics, 3(3), 768-777. https://doi.org/10.1039/d6pm00014b

Vancouver

Awasthi G, Banerjee S. Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms. RSC Pharmaceutics. 2026;3(3):768-777. doi:10.1039/d6pm00014b

BibTeX
@article{Awasthi2026,
  author = {Awasthi, Gaurav and Banerjee, Subham},
  title = {Merged in silico – in vitro validations of atenolol and amlodipine besylate with excipient interactions for the design of solid oral dosage forms},
  journal = {RSC Pharmaceutics},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {768--777},
  doi = {10.1039/d6pm00014b}
}
Kostenlos starten →